Welcome to CDC stacks | Interim estimates of 2017–18 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network - 59903 | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Interim estimates of 2017–18 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network
Filetype[PDF-363.44 KB]


Details:
  • Supporting Files:
    No Additional Files
    1. Influenza surveillance update
      Personal Author:
      Brammer, Lynnette
      Corporate Author:
      National Center for Immunization and Respiratory Diseases (U.S.)
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
      Published:
      3/29/18
      Series:
      ACIP meeting Influenza
      Description:
      Presentations February 2018 Day 1 : Publication date from document properties. : flu-03-Brammer-508.pdf
      File Type:
      Filetype[PDF - 877.17 KB]
    2. Fluarix quadrivalent : efficacy in children 6–35 months of age : results of a randomized trial
      Personal Author:
      Friedland, Leonard
      Corporate Author:
      GSK Vaccines.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
      Published:
      4/4/18
      Series:
      ACIP meeting Influenza
      Description:
      Presentations February 2018 Day 1 : Publication date from document properties. : flu-02-Friedland-508.pdf
      File Type:
      Filetype[PDF - 1.30 MB]
    3. VFC resolution update: Influenza vaccines
      Personal Author:
      Santoli, Jeanne M.
      Corporate Author:
      National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
      Published:
      4/3/18
      Series:
      ACIP meeting Influenza
      Description:
      Presentations February 2018 Day 1 : Publication date from document properties. : flu-07-Santoli-508.pdf
      File Type:
      Filetype[PDF - 357.24 KB]
    4. Results of randomized trial of a new H1N1 LAIV strain in US children
      Personal Author:
      Mallory, Raburn
      Corporate Author:
      MedImmune, Inc.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
      Published:
      3/29/18
      Series:
      ACIP meeting Influenza
      Description:
      Presentations February 2018 Day 1 : Publication date from document properties. : flu-05-Mallory-508.pdf
      File Type:
      Filetype[PDF - 285.21 KB]
    5. Review of effectiveness of live attenuated influenza vaccine
      Personal Author:
      Grohskopf, Lisa A.
      Corporate Author:
      National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
      Published:
      4/2/18
      Series:
      ACIP meeting Influenza
      Description:
      Presentations February 2018 Day 1 : Publication date from document properties. : /flu-06-Grohskopf-508.pdf
      File Type:
      Filetype[PDF - 1.55 MB]
    6. Influenza session
      Personal Author:
      Walter, Emmanuel B.
      Corporate Author:
      United States. Advisory Committee on Immunization Practices. Influenza Work Group.
      Conference Author:
      United States. Advisory Committee on Immunization Practices. Meeting (2018 February 21-22 : Atlanta, GA)
      Published:
      3/27/18
      Series:
      ACIP meeting Influenza
      Description:
      Presentations February 2018 Day 1 : Publication date from document properties. : flu-01-Walter-508.pdf
      File Type:
      Filetype[PDF - 162.78 KB]
You May Also Like:
  1. Interim estimates of 2016–17 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network
    Personal Author:
    Flannery, Brendan; Chung, Jessie R.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2017 February 22-23 : Atlanta, GA)
    Published:
    3/27/2017
    Series:
    ACIP meeting Influenza
    Description:
    Presentations February 2017 Day 1 : On the agenda, this presentation listed as: Vaccine effectiveness update. : influenza-03-flannery.pdf
    File Type:
    Filetype[PDF - 331.12 KB]
  2. Interim estimates of 2018–19 seasonal influenza vaccine effectiveness against medically attended influenza from the US Flu VE Network
    Personal Author:
    Flannery, Brendan; Chung, Jessie R.; Doyle, Joshua D.;
    Corporate Author:
    National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network.
    Conference Author:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
    Published:
    February 27, 2019
    Series:
    ACIP meeting Influenza
    Description:
    flu-3-Flannery-508.pdf
    File Type:
    Filetype[PDF - 424.94 KB]
  3. Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018
    Personal Author:
    Flannery, Brendan; Chung, Jessie R.; Belongia, Edward A.; McLean, Huong Q.; Gaglani, Manjusha; Murthy, Kempapura; Zimmerman, Richard K.; Nowalk, Mary Patricia; Jackson, Michael L.; Jackson, Lisa A.; Monto, Arnold S.; Martin, Emily T.; Foust, Angie; Sessions, Wendy; Berman, LaShondra; Barnes, John R.; Spencer, Sarah; Fry, Alicia M.;
    Published:
    Feb 16 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(6):180-185.
    Description:
    In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months (1). During each influenza season since 2004-05, CDC has estimated the effectiveness of seasonal influenza vaccine to prevent laborato...
    File Type:
    Filetype[PDF - 248.42 KB]
  4. Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017
    Personal Author:
    Flannery, Brendan; Chung, Jessie R.; Thaker, Swathi N.; Monto, Arnold S.; Martin, Emily T.; Belongia, Edward A.; McLean, Huong Q.; Gaglani, Manjusha; Murthy, Kempapura; Zimmerman, Richard K.; Nowalk, Mary Patricia; Jackson, Michael L.; Jackson, Lisa A.; Foust, Angie; Sessions, Wendy; Berman, LaShondra; Spencer, Sarah; Fry, Alicia M.;
    Published:
    Feb 17 2017
    Source:
    MMWR Morb Mortal Wkly Rep. 66(6):167-171.
    Description:
    In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months (1). Each influenza season since 2004-05, CDC has estimated the effectiveness of seasonal influenza vaccine to prevent influenza-assoc...
    File Type:
    Filetype[PDF - 240.97 KB]
  5. Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019
    Personal Author:
    Doyle, Joshua D.; Chung, Jessie R.; Kim, Sara S.; Gaglani, Manjusha; Raiyani, Chandni; Zimmerman, Richard K.; Nowalk, Mary Patricia; Jackson, Michael L.; Jackson, Lisa A.; Monto, Arnold S.; Martin, Emily T.; Belongia, Edward A.; McLean, Huong Q.; Foust, Angie; Sessions, Wendy; Berman, LaShondra; Garten, Rebecca J.; Barnes, John R.; Wentworth, David E.; Fry, Alicia M.; Patel, Manish M.; Flannery, Brendan;
    Published:
    February 15 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(6):135-139
    Description:
    In the United States, annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months (https://www.cdc.gov/flu/protect/whoshouldvax.htm). Effectiveness of seasonal influenza vaccine varies by season. During each influenz...
    File Type:
    Filetype[PDF - 102.23 KB]